Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-035619

Options or other derivatives

  • Chief Commercial Officer acquired 6,219,696 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Piccina Cintia Chief Commercial Officer 2024-03-18 Grant or award · Option to purchase Ordinary Shares +5,088,864 5,088,864 D
Piccina Cintia Chief Commercial Officer 2024-03-18 Grant or award · Option to purchase Ordinary Shares +1,130,832 1,130,832 D
Loading xslF345X05/tm249079d1_4seq1.xml…